Literature DB >> 10330279

Co-ligation of CD44 on naive human tonsillar B cells induces progression towards a germinal center phenotype.

S Ingvarsson1, K Dahlenborg, R Carlsson, C A Borrebaeck.   

Abstract

The precise signaling pathways to induce a germinal center (GC) phenotype and somatic mutations in human B cells are presently not understood. Major phenotypical hallmarks of a human GC B cell are up-regulated expression of CD10 and CD95 together with a heterogeneous expression of CD77. Activation of resting human tonsillar B cells using anti-CD40 and anti-IgM antibodies normally only induces up-regulation of CD38 and CD71 but has no effect on the typical GC markers. However, we show here that an additional co-ligation of the glycoprotein CD44 on such tonsillar B cells up-regulated the typical human GC markers CD10, CD38, CD77 and CD95, and down-regulated CD24 and CD39 as well as induced progression towards apoptosis in these cells; all characteristics of GC B cells. These data indicate a functional role of CD44 during activation of human naive B lymphocytes and in the generation of GC B cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330279     DOI: 10.1093/intimm/11.5.739

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  3 in total

Review 1.  Fortifying B cells with CD154: an engaging tale of many hues.

Authors:  J Gordon; J D Pound
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

2.  CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.

Authors:  Dianne Pulte; Richard R Furman; M Johan Broekman; Joan H F Drosopoulos; Harold S Ballard; Kim E Olson; Jorge R Kizer; Aaron J Marcus
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-08

3.  CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.

Authors:  Dianne Pulte; Kim E Olson; M Johan Broekman; Naziba Islam; Harold S Ballard; Richard R Furman; Ashley E Olson; Aaron J Marcus
Journal:  J Transl Med       Date:  2007-05-04       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.